These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9096196)

  • 61. Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.
    Rouse MS; Tallan BM; Steckelberg JM; Henry NK; Wilson WR
    Antimicrob Agents Chemother; 1992 Jan; 36(1):56-8. PubMed ID: 1590700
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Renal tolerance with the use of intralipid-amphotericin B in low-birth-weight neonates.
    Friedlich PS; Steinberg I; Fujitani A; deLemos RA
    Am J Perinatol; 1997 Aug; 14(7):377-83. PubMed ID: 9263555
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
    Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
    Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
    [No Abstract]   [Full Text] [Related]  

  • 64. [Anti-infectious effect of sustained antravitreal amphotericin B drug delivery system on experimental rabbit fungal endophthalmitis of Candida albicans].
    Chen N; Yang YT; Dong XG; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):420-5. PubMed ID: 16762236
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.
    Caillot D; Chavanet P; Casasnovas O; Solary E; Zanetta G; Buisson M; Wagner O; Cuisenier B; Bonnin A; Camerlynck P
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):722-5. PubMed ID: 1425731
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of the efficacy of polyenes and triazoles against hematogenous Candida krusei infection in neutropenic mice.
    Karyotakis NC; Anaissie EJ; Hachem R; Dignani MC; Samonis G
    J Infect Dis; 1993 Nov; 168(5):1311-3. PubMed ID: 8228370
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amphotericin B intralipid formulation: stability and particle size.
    Ranchère JY; Latour JF; Fuhrmann C; Lagallarde C; Loreuil F
    J Antimicrob Chemother; 1996 Jun; 37(6):1165-9. PubMed ID: 8836819
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Successful lipid-complexed amphotericin B treatment of Candida arthritis in a lymphoma patient.
    Azaceta G; Olave T; de los Martires LD; Delgado C; Gutierrez M; Palomera L
    Rev Rhum Engl Ed; 1999; 66(7-9):434-5. PubMed ID: 10526387
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Amphotericin B dosage for disseminated candidiasis in premature infants.
    Hall JE; Cox F; Karlson K; Robertson A
    J Perinatol; 1987; 7(3):194-8. PubMed ID: 3332892
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amphotericin B--fat emulsion in treatment of visceral leishmaniasis--a cost effective substitute for liposomal amphotericin B.
    Singh GP; Saxena RK; Priyadarshy V
    J Indian Med Assoc; 2010 Jan; 108(1):27-8. PubMed ID: 20839576
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis.
    Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2009 Dec; 34(6):566-9. PubMed ID: 19733036
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature.
    Wasan KM; Sivak O; Bartlett K; Wasan EK; Gershkovich P
    Drug Dev Ind Pharm; 2015; 41(9):1425-30. PubMed ID: 25170660
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Amphotericin B: emergency challenge in a neutropenic, asthmatic patient with fungal sepsis.
    Kemp SF; Lockey RF
    J Allergy Clin Immunol; 1995 Sep; 96(3):425-7. PubMed ID: 7560647
    [No Abstract]   [Full Text] [Related]  

  • 75. Combined amphotericin B and rifampin treatment of experimental Candida albicans keratitis.
    Stern GA; Okumoto M; Smolin G
    Arch Ophthalmol; 1979 Apr; 97(4):721-2. PubMed ID: 426691
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of experimental disseminated candidiasis with cilofungin.
    Perfect JR; Hobbs MM; Wright KA; Durack DT
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1811-2. PubMed ID: 2589848
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fluconazole or amphotericin for candidosis in neutropenic patients.
    Soutar RL
    Lancet; 1991 Jan; 337(8734):181. PubMed ID: 1670824
    [No Abstract]   [Full Text] [Related]  

  • 78. Candida tropicalis.
    Gelfand MS
    Infect Control Hosp Epidemiol; 1989 Jun; 10(6):280-3. PubMed ID: 2661684
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor.
    Gonzalez CE; Couriel DR; Walsh TJ
    Clin Infect Dis; 1997 Feb; 24(2):192-6. PubMed ID: 9114146
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B.
    Solomkin JS; Flohr A; Simmons RL
    Ann Surg; 1982 Feb; 195(2):177-85. PubMed ID: 7055395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.